PNV 1.47% $2.01 polynovo limited

Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial, page-37

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,861 Posts.
    lightbulb Created with Sketch. 371
    As an amateur, I think that the complete healing of an ulcer in 12 weeks is job done for SyPath. What happens afterwards, say 12 months down the track, could be down to a multitude of other things unrelated to the completed healing process e.g., an injury to the site. In other words, it seems obvious that complete healing is the desired and most reasonable outcome for a study of efficacy of this kind. But what is obvious to an amateur might be bollocks to a professional so I have written this with some trepidation.
    Last edited by Puzzled: 10/08/22
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.01
Change
-0.030(1.47%)
Mkt cap ! $1.388B
Open High Low Value Volume
$2.02 $2.04 $1.99 $2.209M 1.099M

Buyers (Bids)

No. Vol. Price($)
2 12000 $1.99
 

Sellers (Offers)

Price($) Vol. No.
$2.01 4996 1
View Market Depth
Last trade - 16.10pm 18/11/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.